• TRM (USD/COP)COP 3,461.92 +1.37% +COP 46.82Colombia's official exchange rate (Financial Superintendence), valid Nov 21 to Nov 23
  • EuroCOP 3,804.64 +1.37% +COP 51.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
  • Mexican pesoCOP 181.56 +1.37% +COP 2.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
← Back to the community
Finance

Fasecolda Insurers Hit COP 61T in Premiums and COP 27.6T in Claims: How Do Reserve Yields Protect a 16% ROE?

Whenever friends outside the financial sector ask me how Colombian insurance companies manage to post a ~16% Return on Equity (ROE) right in the middle of a national healthcare crisis, I always tell them to stop looking only at policy underwriting and look at our fixed-income trading desks. According to Fasecolda and the Superintendencia Financiera de Colombia (SFC), our industry reached a record COP 61 trillion in annual written premiums (+8.8% nominal, +3.5% real, representing 3.29% of Colombia's GDP and COP 1.15 million per capita) plus another COP 30 trillion in H1 2026. On the surface, that looks like a boom—until you look at the claims side of the ledger, where payouts jumped to COP 27.6 trillion.

Working inside an actuarial and reserve portfolio team in Bogotá, you see three structural claim storms hitting at the exact same time. First, because families are terrified of bottlenecks in the public EPS and ADRES health system, everyone who can afford a private health policy at Suramericana / Grupo Sura (BVC: GRUPOSURA), Seguros Bolívar / Grupo Bolívar (BVC: GRUBOLIVAR), Allianz Colombia, or AXA Colpatria is using it intensively—driving private health claims up a massive 21% YoY to COP 3.30 trillion. Second, we absorbed COP 1.26 trillion in catastrophic seismic and climate claims alongside chronic SOAT road-accident losses. Third, for life insurers like Positiva and Seguros Alfa, every time Colombia's minimum wage rises above inflation, the mathematical reserves required by the SFC for life annuities ('rentas vitalicias') expand overnight. The only reason the industry still delivers a 16% ROE despite a ~40% effective corporate tax rate is 'insurance float': investing tens of trillions of pesos of compulsory technical reserves into Colombian sovereign TES bonds and AAA corporate debt yielding 10% to 13% E.A.

That brings us to the real dilemma for 2026 and 2027. As the Banco de la República gradually trims policy rates and reinvestment yields on short-term fixed income start to compress, that financial cushion gets thinner every quarter. If you hold Grupo Sura or Grupo Bolívar on the BVC—or if you're simply renewing your family's health and auto policies this year—do you think high long-end TES yields will keep subsidizing Colombian insurers' 16% ROE, or are we heading into a wave of 15%–20% premium hikes to cover medical inflation?

How will Colombian insurers defend their 16% ROE as health claims surge?

0 votes

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.